Documente Academic
Documente Profesional
Documente Cultură
Phase IIIB
Case Summary
Name
:5
She was a non-smoker and does not consume alcohol. She worked as a hawker
who sells soya bean drinks and had retired. Her husband passed away 4 years
ago and currently she stays with her only son. She is full independent performing
Activities of Daily Living (ADL). She is financially constraint due to the high cost
of chemotherapy and she is not eligible for free treatment.
Summary
Madam Nelmawati, a 57-year-old Malay lady presented with left sided chest
heaviness which was aggravated by lying down and relieved by sitting. She was
diagnosed with stage 4 Diffuse Large B-Cell Lymphoma and currently on 4 th cycle
of R-CHOP chemotherapy. Other issues include dyslipidaemia and financial
difficulty.
Chest examination
The notable finding is in the lower zone of left posterior lung. There is reduce
chest expansion, stony dullness percussion, reduced vocal resonance and reduce
breath sound, which suggestive of left sided pleural effusion.
Trachea is not deviated, no raised jugular venous pressure, no parasternal heave
and palpable P2.
Skin examination
There is a 7cm x 4 cm non-tender, hard lump over the gluteal region. It does not
attached to the skin. There is no overlying skin changes.
There is a 3cmx2cm non-tender soft lump over the scalp of left parietal region.
There is crusting of skin.
Cardiovascular, abdomen and neurological examination are normal.
Provisional Diagnosis
Left-sided pleural effusion due to health-care associated pneumonia
Differential Diagnosis
Left-sided pleural effusion secondary to lung metastasis
Pulmonary Tuberculosis
Dengue in critical phase
Investigations
1. Full blood count, liver function test, renal function
Date
Hb
Platelet
WBC
Neutrophil
26/9
108
152
2.3
0.92
27/9
29/9
103
179
7.1
3.62
Na+
K+
Urea
Creatinine
135
2.8
1.8
51
139
3
4.8
47
139
3.6
1.8
45
Total Protein
Albumin
Total Bilirubin
ALP
ALT
Ca+
Mg+
33
10
156
37
2.34
0.7
64
37
8
163
27
2.2
0.7
Discussion
For patient like Madam Nelmawati who has underlying stage 4 DLBCL undergoing
cytotoxic therapy, it is common to have neutropenia. Her neutrophil count at
day-care was 920/mm3. Besides, her vitals sign upon admission was also fulfilled
4 out of 4 criteria of SIRS, as she was febrile, tachycardia and tachypnoea.
Febrile neutropenia is defined as single oral temperature of 38.3 C OR a
temperature 38.0 C for 1 hour; while neutropenia defined as neutrophil count
of <500 cells/mm3, or count of ,1000 cells/mm3 with predicted decline to <500
cells/mm3. Hence, Madam Nelmawati has neutropenic sepsis.
Symptomatically, she only has chest heaviness without chill. This is not
uncommon; as inflammatory response may be minimal especially in severely
neutropenic patient. Usually, in pleural effusion, patient will have progressively
worsening dyspnoea and minimal cough. Causes of pleural effusion may be due
to TB, parapneumonic effusion, lung metastasis, or even plasma leakage in
critical phase of dengue. Unfortunately, pleural fluid analysis was unable to be
performed as there is dry tap.
Actually, Madam Nelmawati was admitted to hospital 3 weeks ago due to
neutropenic fever secondary to parapneumonic effusion. During that admission,
pleural fluid culture showed Pseudomonas growth and her blood culture showed
Kleibsiella pneumoniae growth. However, blood culture is negative during this
admission.
Efforts have been made to formulate risk-stratification models for neutropenic
patiens, and one of the most used models is Multinational Association of
Supportive Care in Cancer (MASCC) Risk Scoring Index to identify low risk
patients as they may be considered for outpatient management. Madam
Nelmawati scored 28/30, which is considered as low risk patient.
Madam Nelmawati was started on IV Tazocin, considered that she has a previous
Pseudomonas infection. She improved clinically, although there is still left sided
pleural effusion on imaging. Her white cell count also normalized and she was no
longer neutropenic. She was discharged after hospitalized for 5 days and was
prescribed with oral Augmentin.